Literature DB >> 8231256

Detection of circulating tumor cells in multiple myeloma by a PCR-based method.

P Corradini1, C Voena, P Omedé, M Astolfi, M Boccadoro, R Dalla-Favera, A Pileri.   

Abstract

Multiple myeloma (MM) is a B-cell malignancy characterized by clonal expansion of plasma cells producing monoclonal immunoglobulins. It has been regarded as a tumor typically involving only the bone marrow. The existence of circulating tumor cells has been suggested from phenotypic and genotypic studies. However, this issue is still controversial due to the limitations of the methods so far used. We describe a novel polymerase chain reaction (PCR) based method using clone-specific immunoglobulin heavy-chain gene sequences as tumor markers. From such sequences patient-specific oligonucleotide primers and probes were generated, and used to detect tumor cells. Seven MM patients were selected for this study, and tumor cells were found in all peripheral blood samples. The demonstration of circulating tumor cells suggests some caution when using peripheral blood for autograft procedures, even though its contamination is lower than bone marrow. In conclusion, we describe a specific and sensitive PCR-based method for detecting minimal disease which is of general applicability to all lymphoid malignancies transcribing rearranged immunoglobulin heavy-chain genes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8231256

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  Assessment of IgH PCR strategies in multiple myeloma.

Authors:  R G Owen; R J Johnson; A C Rawstron; P A Evans; A Jack; G M Smith; J A Child; G J Morgan
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

Review 2.  Detection of minimal residual disease in multiple myeloma and acute leukaemia.

Authors:  M H Bakkus; N Juge-Morineau; J E van der Werff ten Bosch
Journal:  Med Oncol       Date:  1996-06       Impact factor: 3.064

3.  The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype.

Authors:  Shmuel Yaccoby
Journal:  Clin Cancer Res       Date:  2005-11-01       Impact factor: 12.531

4.  Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?

Authors:  S Z Usmani; J Crowley; A Hoering; A Mitchell; S Waheed; B Nair; Y AlSayed; F Vanrhee; B Barlogie
Journal:  Leukemia       Date:  2012-06-18       Impact factor: 11.528

5.  Detection of clonal immunoglobulin gene rearrangements in the peripheral blood progenitor cells of patients with multiple myeloma: the potential role of purging with CD34 positive selection.

Authors:  R G Owen; A P Haynes; P A Evans; R J Johnson; A C Rawstron; G McQuaker; G M Smith; M C Galvin; D L Barnard; N H Russell; J A Child; G J Morgan
Journal:  Clin Mol Pathol       Date:  1996-04

6.  Phenotypic detection of clonotypic B cells in multiple myeloma by specific immunoglobulin ligands reveals their rarity in multiple myeloma.

Authors:  Martin Trepel; Victoria Martens; Christian Doll; Janina Rahlff; Barbara Gösch; Sonja Loges; Mascha Binder
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

Review 7.  Cancer metastasis chemoprevention prevents circulating tumour cells from germination.

Authors:  Xiaodong Xie; Yumei Li; Shu Lian; Yusheng Lu; Lee Jia
Journal:  Signal Transduct Target Ther       Date:  2022-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.